Omnicell

JANUARY 10, 2023

Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. Read more about the Omnicell-AHN Partnership in this week’s press release.

Sterile Compounds 97

Sterile Compounds Omnicell Compounding Hospitals 97

Omnicell

JANUARY 10, 2023

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Studies have shown that one out of every ten can put patients at risk. Insourcing IV compounding services at Moses H. 5 at 2 p.m.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

JANUARY 10, 2023

The latest revisions, which take effect November 1, 2023, exempt some robotic devices from surface sampling after every batch of Category 3 compounded sterile products (CSPs) and instead allow users of self-enclosed robotic devices to surface sample once per day.

Sterile Compounds 98

Sterile Compounds Compounding Omnicell Patient Care 98

Omnicell

JANUARY 10, 2023

Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

JANUARY 10, 2023

Omnicell is partnering with the Autonomous Pharmacy Advisory Board to transform the pharmacy care model through technology-enabled solutions and delivering expert services, supporting the journey to “zero error” through the Autonomous Pharmacy.

Hospitals 52

Hospitals Sterile Compounds Omnicell Patient Care 52

Omnicell

JANUARY 10, 2023

Ken Osborn Senior Director, Product Marketing, Omnicell As medication management continues to be one of the top challenges of healthcare today, Omnicell’s commitment to delivering the innovation to navigate and streamline the complexities of the pharmacy care delivery model is stronger than ever.

Controlled Substances 52

Controlled Substances Omnicell Compounding Sterile Compounds 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding 52

Compounding Sterile Compounds Omnicell Patient Care 52